Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 36799 clinical trials
Impact of the Comprehensive Geriatric Assessment on the Quality of Life OF Elderly Patients

Impact of the Comprehensive Geriatric Assessment on the Quality of Life of elderly onco-hematologic patients' candidates for complex antitumoral therapies: clinical and biological correlatives

hematologic malignancy
cancer
  • 0 views
  • 05 Aug, 2020
Natural History Study of Children and Adults With Neuroendocrine Neoplasms (NEN)s

Background Neuroendocrine neoplasms (NENs) are rare tumors that originate in neuroendocrine cells. NENs can affect almost any part of the body. People with low-grade tumors can live many years.

calcitonin
blood test
positron emission tomography
5-hydroxyindoleacetic acid
proinsulin
  • 0 views
  • 05 Aug, 2020
RadioPathomics Artificial Intelligence Model to Predict Tumor Regression Grading in Locally Advanced Rectal Cancer

In this study, investigators apply a radiopathomics artificial intelligence (AI) supportive model to predict neoadjuvant chemoradiotherapy (nCRT) response before the nCRT is delivered for the patients with locally advanced rectal cancer (LARC). The radiopathomics AI system predicts individual tumor regression grading (TRG) category based on each patient's radiopathomics features extracted …

MRI
adenocarcinoma
rectal cancer
adjuvant
adenocarcinoma of rectum
  • 0 views
  • 16 Feb, 2024
  • 3 locations
Locoregional Surgery of the Primary Tumor in de Novo Stage IV Breast Cancer Patients

Current guidelines lack definitive evidences about the relative benefits of locoregional surgery for the primary tumor in de novo stage IV breast cancer. The aim of this study (SYSBTC-001) was to investigate the role of locoregional surgery for primary tumor in de novo stage IV breast cancer.

invasive breast cancer
breast cancer
metastasis
primary lesion
cancer
  • 0 views
  • 16 Feb, 2024
  • 3 locations
PRISM: Patient Experiences With PET Imaging in Prostate Cancer (PRISM)

The purpose of this study is to examine patient experiences, health-related quality of life, and decision-making associated with PET imaging for prostate cancer. In particular, Prostate Specific Membrane Antigen (PSMA) PET, a new and more sensitive form of imaging that can help identify metastatic cancer earlier and more reliably.

  • 0 views
  • 05 Nov, 2025
Determination of Blood Tumor Cells

Magnetic nanoparticles coated with anti-EpCAM or anti-CD52 antibodies will be tested ex-vivo in patients blood .

lymphoma
leukemia
hematologic malignancy
cancer
  • 0 views
  • 16 Feb, 2024
  • 1 location
Natural History Study of Children and Adults With Adrenocortical Cancer (ACC)

Background Adrenocortical cancer (ACC) is a rare tumor. The prognosis is very poor for people with advanced stages of ACC. Some people may live with ACC for years; others live for just months.

adrenal
cancer
solid tumors
adrenocortical carcinoma
blood tests
  • 0 views
  • 16 Feb, 2024
  • 1 location
Immune Profiling After HDR in Local Relapsed Prostate Cancer

Immunotherapy is currently revolutionizing the field in oncology. However, prostate cancer until now fails to respond to classical IO, like PD-1 and CTLA-4 inhibitors. Radiotherapy (RT) delivered to the primary tumor impacts both tumor cells and surrounding stromal cells.

brachytherapy
primary tumor
tumor cells
multiparametric magnetic resonance imaging
  • 0 views
  • 16 Feb, 2024
  • 1 location
Fertility After Prostate Brachytherapy

Although brachytherapy toxicity data on erectile dysfunction, urethral dysfunction and bladder and bowel impact has been collected for a number of years, there is limited information on its effect on male fertility. This study aims to investigate the effect of brachytherapy on fertility

brachytherapy
impotence
  • 0 views
  • 16 Feb, 2024
  • 1 location
Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris Testing

This registry will evaluate treatment selection for patients with newly diagnosed, localized prostate cancer following Prolaris testing. It will measure the proportion of men who initially select treatment with active surveillance, the time frame between active surveillance selection and any change in treatment, and clinical outcomes.

prolaris testing
adenocarcinoma
adenocarcinoma of prostate
  • 0 views
  • 05 Aug, 2020